Spinal Surgery Devices And Equipment Global Market Report 2023 – By Product Type (Spine Biologics, Surgical Spinal Decompression, Vertebral Compression Fracture Treatment Products, Non-Fusion, Fusion), By Application (Hospital, Ambulatory Service Centers, Orthopedic Centers), By Type of Surgery (Open Surgeries, Minimally Invasive Surgeries) – Market Size, Trends, And Global Forecast 2023-2032

Spinal imaging refers to the radio waves, and magnetic fields, that are used in magnetic resonance imaging (MRI) of the spine. It generates comprehensive images of the spine and adjacent tissues. Spinal imaging is used to monitor changes in the spinal cord such as compression fracture, and bone swelling, and used to track changes in the spine post-surgery, such as scarring or infection. The main types of spinal imaging markets products are X-ray, CT, MRI, and Ultrasound. X-ray is used to evaluate any area of the spine. The X-ray refers to myelography, computed tomography, magnetic resonance imaging, and bone scans are other related techniques that may be used to identify spine, back, or neck disorders. The different applications include spinal infection, vertebral fractures, spinal cancer, spinal cord, nerve compressions, and others that are employed in several end users such as hospital, diagnostic imaging centre, and ambulatory care centre. The global spinal imaging market is segmented – 1) By Product: X-Ray, CT, MRI, Ultrasound 2) By Application: Spinal Infection, Vertebral Fractures, Spinal Cancer, Spinal Cord and Nerve Compressions, Other Applications 3) By End-User: Hospital, Diagnostic Imaging Center, Ambulatory Care Center The global spinal imaging market size grew from $1.86 billion in 2022 to $2.04 billion in 2023 at a compound annual growth rate (CAGR) of 9.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global spinal imaging is expected to grow to $2.76 billion in 2027 at a CAGR of 7.8%. The growing volume of spinal cord injuries (SCI) is driving the growth of the spinal imaging market. Damage to the spinal cord or nerves at the end of the spinal canal due to a sudden, traumatic blow to the vertebrae leading to a fracture or loss of function or mobility in different parts of the body is referred to as a spinal cord injury. Spinal imaging plays an important role in the evaluation of acute and chronic spinal injury and plays an essential role in the diagnosis, treatment, and rehabilitation of spinal cord injury (SCI) patients. For instance, according to the US based The National Spinal Cord Injury Statistical Centre (NSCISC), located at the University of Alabama at Birmingham (UAB) 2020 data, approximately 17,810 new spinal cord injuries happen each year in the US that is approximately 294,000 people with SCI live in the US with a range of 250,000 to 368,000 persons. Therefore, a growing volume of spinal cord cancer is expected to drive the growth of the spinal imaging market. Major players in the spinal imaging market are GE Healthcare, Koninklijke Philips N.V., Siemens Healthineers, Canon Medical Systems Corp., Bruker Corporation., Mediso Ltd., Shimadzu Corp., Fujifilm Healthcare, Hitachi Ltd., Toshiba Medical Systems Inc., Carestream Health Inc., Ramsoft Technologies Private Limited, Sonic Healthcare Limited, Carl Zeiss Meditec AG, InHealth Group, Alliance Healthcare Providers Llp, MEDNAX Services Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., 3M Company, 7D Surgical Inc., Alphatec Holdings Inc., Becton Dickinson India Private Limited, Gpc Medical Limited, Invibio Ltd., Medtronic PLC, Narang Medical Limited, Novartis AG, NuVasive Inc., Sanofi S.A., and Shimadzu Corporation. Technological advancement is a key trend gaining popularity in the spinal imaging market. Major companies operating in the market are developing new advanced technologies to reinforce their position and meet customer demand. For instance, in March 2021, RIVANNA, a US-based company providing imaging-based medical solutions, launched Accuro Second Generation, a spinal navigation system. This system uses artificial intelligence technology to provide medical solutions. The Accuro spinal navigation system has two key innovations: SpineNav3DTM AI-Based Spine Recognition, which automates the identification of spinal landmarks and depth measurements during spinal needle guidance procedures, and BoneEnhance Multi-Frequency Image Reconstruction, which improves bone-to-tissue contrast for better landmark and needle visualization. In August 2022, Wenzel Spine, Inc., a US-based medical technology firm specializing in minimally invasive treatments for spinal diseases, acquired Statera Spine for an undisclosed amount. Through this acquisition, Wenzel Spine offered complete solutions to spine surgeons and their patients with innovative diagnostic and planning tools that complemented their already cutting-edge minimally invasive implant technology. Statera Spine is a US-based software-enabled spine imaging analytics company. North America was the largest region in the spinal imaging market in 2022. Asia-Pacific is expected to be the fastest-growing region in the spinal imaging market share during the forecast period. The regions covered in the spinal imaging market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the spinal imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The spinal imaging market consists of sales of image processing, image display equipment, storage archiving equipment, and picture archiving and communication system. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The spinal imaging market research report is one of a series of new reports from The Business Research Company that provides spinal imaging market statistics, including spinal imaging industry global market size, regional shares, competitors with a spinal imaging market share, detailed spinal imaging market segments, market trends and opportunities, and any further data you may need to thrive in the spinal imaging industry. This spinal imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Spine implants are the devices used to correct the deformity in the spine, stabilise and strengthen the spine, and facilitate the fusion of bones in different disorders such as degenerative disc disease, kyphosis, scoliosis, spondylolisthesis, spinal stenosis, and fracture. The main products in the spine implants market are spinal fusion devices, non-fusion devices/motion preservation devices, vertebral compression fracture (VCF) treatment devices, spinal bone stimulators, and spine biologics. The spinal fusion devices provide a solution for spinal instability and are designed specifically to treat spinal disorders. They use surgical procedures to implant titanium-alloy, titanium, stainless steel, and non-metallic devices into the spine. Open surgery and minimally invasive surgery (MIS) are among the procedures involved.The various materials in spine implants include metallic, polymeric, and ceramic. The spine implants market are used in hospitals, specialty orthopaedic and spine centres, and ambulatory surgical centres. The global spine implants market is segmented - 1) By Product: Spinal Fusion Devices, Non-Fusion Devices/Motion Preservation Devices, Vertebral Compression Fracture (VCF) Treatment Devices, Spinal Bone Stimulators, Spine Biologics 2) By Procedure: Open Surgery, Minimally Invasive Surgery (MIS) 3) By Material: Metallic, Polymeric, Ceramic 4) By End Use: Hospitals, Specialty Orthopedic And Spine Centers, Ambulatory Surgical Centers The global spine implants market size grew from $11.32 billion in 2022 to $12.33 billion in 2023 at a compound annual growth rate (CAGR) of 8.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global spine implants is expected to grow from $16.86 billion in 2027 at a CAGR of 8.1%. The rising incidences of spinal disorders coupled with the usage of minimally invasive surgical procedures are contributing to the growth of the global spine implants market. According to Branko PRPA, surgical in September 2021, annually there are 1.34 to 4.6 spinal cases per million and 1,400 new cases diagnosed each year, with 33,000 having some type of disability in the US and among them, 30% of the adult female population suffers from lower back pain, compared to 25 percent of the adult male adult population and this is approximately 31% of men acknowledged that their condition affects their employment compared to 20% of women. In 2021, the prevalence of neuropathic pain was found to be between 16% and 55%. And due to the emergence of minimally invasive spine surgical (MISS) approaches, it has now become feasible and efficient for treating a wide range of spinal disorders without long incisions and by avoiding significant damage to muscles surrounding the spine, thereby resulting in fewer post-operative pains and faster recovery. Therefore, the increased prevalence of spinal disorders along with the ease in treatment by MISS approaches is driving the global spinal implants market. Major players in the spine implants market are Medtronic, Depuy Synthes, Johnson & Johnson, Stryker Corporation, NuVasive, Inc., Zimmer Biomet Holdings, Globus Medical, Alphatec Holdings, Orthofix International, and RTI Surgical. The increased treatment procedural cost is acting as a hindrance to the global spinal implants market growth. According to a study published in 2021, approximately 500,000 lumbar spine surgeries were performed in the US. The cost of spinal surgeries has increased by 175% globally and in the US, the annual cost of spine care is estimated at $105 billion per patient annually. Increased treatment procedural costs will increase monetary concerns, limiting the market growth. The innovation of implants in providing minimally invasive and motion-preserving stabilization is a major trend in the spine implants market. For example, RTI Surgical Holdings, a global surgical implant company, has launched the first and only posterior lumbar motion preservation solution, Coflex. Coflex is a differentiated, minimally-invasive, motion-preserving stabilization implant that is FDA PMA-approved for the treatment of moderate to severe lumbar spinal stenosis (LSS). It can be directly implanted following a surgical decompression, without fusing the bones. The device comes in different sizes to fit the patient’s anatomy, and this can be performed even in an outpatient setting. In July 2022, Spineway, a France-based spinal implants manufacturer acquired Spine Innovations for an undisclosed amount. The acquisition would help Spineway to accelerate its innovation and growth and position itself as a leader in this segment. Spinal Innovations is a French manufacturer of spinal implants. North America was the largest region in the spine implants market in 2022. Western Europe was the second largest region in the spine implants market report. The regions covered in the spine implants analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the spine implant market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The spine implants market consists of sales of cages, plates, rods values, artificial disc and expandable rods. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The spine implants market research report is one of a series of new reports from The Business Research Company that provides spine implants market statistics, including spine implants industry global market size, regional shares, competitors with a spine implants market share, detailed spine implants market segments, market trends and opportunities, and any further data you may need to thrive in the spine implants industry. This spine implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cerebrospinal fluid management (CSF) devices and equipment are used in the treatment of hydrocephalus, a condition of excessive accumulation of CSF within the brain. The main types of cerebrospinal fluid (CSF) management devices and equipment are CSF shunts and CSF drainage systems. CSF shunts are the devices used for hydrocephalus treatment. They consist of silastic tubes that divert CSF from the ventricles to other body cavities, like the peritoneum, the right cardiac atrium, or the pleural space. The CSF drainage system types such as ventricular drainage system and lumbar drainage system are used by age groups such as pediatric, adult, and geriatric. The various end-users are hospitals and ambulatory surgical centres. The global cerebrospinal fluid management (CSF) devices and equipment market is segmented - 1) By Type: CSF Shunts, CSF Drainage Systems 2) By End User: Hospitals, Ambulatory surgical centers 3) By Age group: Pediatric, Adult, Geriatric 4) CSF Drainage Systems By Type: Ventricular Drainage System, Lumbar Drainage System The global cerebrospinal fluid management (csf) devices and equipment market size will grow from $1.04 billion in 2022 to $1.09 billion in 2023 at a compound annual growth rate (CAGR) of 5.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global cerebrospinal fluid management (csf) devices and equipment is expected to grow to $1.15 billion in 2027 at a CAGR of 1.2%. The increase in the number of brain surgeries drives the market for cerebrospinal fluid (CSF) devices. CSF devices play a major role in the treatment of traumatic brain injury (TBI), shunts are devices used in the CSF procedure which ensure that any cerebrospinal fluid accumulated near the brain gets drained out. In the United States, one of the leading causes of death is TBI and approximately 1.5 to 2 million adults and children suffer a traumatic brain injury (TBI) each year. Among the 1.1 million who face head injury, 235,000 individuals will be hospitalized with a moderate to severe head injury while approximately 50,000 face death. However, a majority of them will have a mild injury that does not require admission to the hospital. With such an increase in the number of brain injuries, the CSF devices market will continue to grow. Major players in the cerebrospinal fluid (CSF) management devices and equipment market report are B. Braun, DePuy Synthes, Integra Life Sciences, Medtronic, Sophysa, BeckerSmith Medical Inc., Möller Medical GmbH, Spiegelberg GmbH & Co. KG, Dispomedica GmbH, and Terumo Corporation. The high possibility of shunt failure or malfunctioning is a major factor restraining the cerebrospinal fluid (CSF) devices market. Shunts are devices used to restrict Hydrocephalus, which is a condition where there is an excess accumulation of cerebrospinal fluid (CSF) near the brain which can cause loss of brain tissues and even impair the brain. According to a study published on National Library of Medicine, in 2021, 30% of procedures incurred complications within 30 days of shunting procedure, 58% required minimum one revision during follow-up. 29.8% of the cases of revision were due to misplacement of hardware. Due to such a high failure rate of shunts, it causes trust deficiency in patients, and as a result, patients look for alternative treatments. Implementing new and improved sensors is the latest trend in the cerebrospinal fluid devices market, this may provide the market with the much-needed boost to improve its growth rate while at the same time improving the quality of the diagnosis. Treatment of Hydrocephalus, which is a condition where there is an excess accumulation of CSF near the brain is a very complex process with many complications. High precision devices are required to improve the quality and success rate of shunt treatments, with the help of technology, new sensors, and telemetry devices are being explored. A cutting-edge new sensor has been developed by the Rogers research group at Northwestern University, Illinois. Researchers at Northwestern believe that their latest skin sensor can greatly reduce malfunctions and the number of brain surgeries. The sensor uses body temperature readings to give information about how much cerebrospinal fluid is leaking. This sensor gives different heat signatures depending on whether the shunt is functional or not. This is a major development in the CSF devices market, the sensor also enables access to information that was previously inaccessible. Currently, the US Food and Drug Administration (FDA) identifies CSF devices as class II devices. As per section 21, subsection 510K certain protocol has to be followed before these devices can be approved. The firms have to list down any possible risks to health and measures taken by them so that the device addresses such health hazards. Apart from this a cover sheet stating that the device is a class II device, a brief description of the device, and a summary report of what the device does and the scope of the device must be duly stated. The last step verifies the device for biocompatibility, performance, and appropriate labeling such as expiration dates, prescriptions, etc. The stringent regulatory guidelines may take time for the product release and increase the overall development cost of the product, thereby impacting the market. North America was the largest region in the global cerebrospinal fluid (CSF) management devices and equipment market in 2022. Asia-Pacific was the second-largest region in the cerebrospinal fluid (CSF) management devices and equipment market share. The regions covered in the global cerebrospinal fluid (CSF) management devices and equipment market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the cerebrospinal fluid (CSF) management devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The cerebrospinal fluid management (CSF) devices and equipment market consists of sales of ventricular drainage system, lumbar drainage system that are used for the treatment of hydrocephalus. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The cerebrospinal fluid (CSF) management devices and equipment market research report is one of a series of new reports from The Business Research Company that provides cerebrospinal fluid (CSF) management devices and equipment market statistics, including cerebrospinal fluid (CSF) management devices and equipment industry global market size, regional shares, competitors with a cerebrospinal fluid (CSF) management devices and equipment market share, detailed cerebrospinal fluid (CSF) management devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cerebrospinal fluid (CSF) management devices and equipment industry. This cerebrospinal fluid (CSF) management devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Minimally invasive surgery devices are surgical tools that require fewer incisions of a smaller size or have a quicker healing process. A minimally invasive medical device is implanted inside the patient during surgery. The main product types of minimally invasive surgery devices are handheld instruments, inflation devices, cutter instruments, guiding devices, electrosurgical devices, auxiliary devices, monitoring and visualization devices. The electrosurgical devices are used to destroy tissue, incise tissue, and control bleeding by coagulating blood. The various applications of minimal invasive surgery devices are laparoscopy, cardiovascular, cosmetic surgery, orthopedic surgery, obstetrics and gynecology, ophthalmology, neurosurgery, urology, and others that are used by end-users such as hospitals, ambulatory surgical centres (ASCS), and research institutes. The global minimal invasive surgery devices market is segmented - 1) By Product Type: Handheld Instruments, Inflation Devices, Cutter Instruments, Guiding Devices, Electrosurgical Devices, Auxiliary Devices, Monitoring & Visualization Devices 2) By Application: Laparoscopy, Cardiovascular, Cosmetic Surgery, Orthopedic Surgery, Obstetrics And Gynecology, Ophthalmology, Neurosurgery, Urology, Other Applications 3) By End Users: Hospitals, Ambulatory Surgical Centers (ASCS), Research Institutes The global minimal invasive surgery devices market size grew from $28.98 billion in 2022 to $31.64 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the minimal invasive surgery devices is expected to grow from $39.48 billion in 2027 at a CAGR of 5.7%. The increasing awareness for minimally invasive surgeries among people is driving the minimally invasive surgery devices market. The minimally invasive surgeries require less/tiny cuts in the skin as compared to traditional surgical methods and aid in lesser pain, short hospital stay, less scarring, minimized chances of bleeding and infections, and low tissue damage. According to the German Heart Surgery Report, the heart operations using ECC (extracorporeal circulation) declined due to achievement of established innovations in minimally invasive therapeutic options in heart surgeries. Furthermore, 51.1% of heart valve operations performed out of the total cardiac surgical procedures in Germany were through the single-valve procedure, out of which 38.5% of them were through minimal invasive heart surgeries. Thus, the growing demand for minimally invasive surgery (MIS) will increase the demand for the minimally invasive surgical devices market. Major players in the minimally invasive surgery devices market are Abbott Laboratories, GE Healthcare, Medtronic PLC., Siemens Healthineers, Smith & Nephew PLC., Medtronic PLC., Stryker Corporation, Boston Scientific Corporation, Ethicon Inc., and B. Braun Melsungen AG. The rising trade barriers are expected to have a negative impact on the minimally invasive surgery devices market growth. Many countries placed trade restrictions, especially on imports, to boost local production. For instance, Brexit is likely to lead to more trade restrictions between the UK and other countries in Europe. The US is also implementing several trade restrictions, especially with China, to boost its local production. For instance, the US government imposed an additional 25% tariff on approximately $16 billion worth of imports from China, including minimally invasive surgical devices and equipment and supplies. These trade restrictions are likely to limit the growth of demand going forward by leading to raised prices. Technologically advanced minimally invasive surgery (MIS) devices with improvements in image guidance, fiber-optics, mini dental implants, and robotic control systems are increasingly opted by patients to treat medical conditions such as aneurysms, cardiac procedures, dental and spinal procedures. Less-invasive surgical procedures with enhanced capabilities in the areas of imaging, micromachining, robotic equipment and components, software systems, and others are becoming popular in the healthcare industry. For instance, video-assisted thoracoscopic surgery (VATS), is a minimally invasive surgical procedure performed to completely remove an organ of the human body to treat traumatic injury, infection, or cancer in the lungs. VATS is performed using a video camera where a small tube called a thoracoscope to which the camera is connected, is inserted through a small incision between the ribs. Furthermore, imaging technology involved in MIS, virtual reality (VR) is becoming a significant area of development. Other MIS techniques are applied to perform surgeries such as single-site laparoscopic surgery, robotic surgeries, needlescopic surgery, cardiac and spinal surgeries, and others. Food and Drug Administration Act (FDA) regulates the minimally invasive surgical devices market in the United States of America. The firms manufacturing robotic minimally invasive surgical devices have to list down any possible risks to health and measures taken by them so that the device addresses health hazards if any stated by FDA. However, the FDA is concerned about the health care providers and patients for not being aware of the safety and effectiveness of these devices as they should not be used in mastectomy procedures or prevention or treatment of cancer. North America was the largest region in the minimally invasive surgery devices market in 2022. Western Europe was the second largest region in the global minimally invasive surgery devices market analysis. The regions covered in the global minimally invasive surgery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the minimally invasive surgery devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The minimally invasive surgery devices market consists of sales of graspers, retractors/elevators, dilators, suturing instruments, laparoscopes, gastroscope, cystoscope, and ureteroscop. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The minimally invasive surgery devices market research report is one of a series of new reports from The Business Research Company that provides minimally invasive surgery devices market statistics, including minimally invasive surgery devices industry global market size, regional shares, competitors with a minimally invasive surgery devices market share, detailed minimally invasive surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the minimally invasive surgery devices industry. This minimally invasive surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical equipment are devices that can be instrument, apparatus or machine that can be used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for health purpose. The main types of medical equipment are in-vitro diagnostics, dental equipment and supplies, ophthalmic devices, diagnostic imaging equipment, cardiovascular devices, hospital supplies, surgical equipment, orthopedic devices, patient monitoring devices, diabetes care devices, nephrology and urology devices, ENT devices, anesthesia and respiratory devices, neurology devices, and wound care devices. In-vitro diagnostics are tests done on samples like blood or tissue that is taken from the human body. In-vitro diagnostics will detect diseases or other conditions and are used to monitor a person’s overall health to cure, treat, or prevent diseases. The type of expenditure involved is public and private. The various product are instruments/equipment and disposables. The various end users involved are hospitals and clinics, homecare, diagnostics centres, and others. The global medical equipment market is segmented - 1) By Type: In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices 2) By Type of Expenditure: Public, Private 3) By Product: Instruments/Equipment, Disposables 4) By End User: Hospitals And Clinics, Homecare, Diagnostics Centers, Other End Users Subsegments Covered: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment, Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment, Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment, X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment, Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment, Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment, Surgical Sutures And Staples, Handheld Surgical Devices And Equipment, Electrosurgical Devices And Equipment, Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, Orthobiologics Devices And Equipment, Arthroscopy Devices And Equipment, Orthopedic Braces And Support Devices And Equipment, Craniomaxillofacial (CMF) Devices And Equipment, Orthopedic Prosthetics, Orthopedic Accessories,, Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment, Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters, Dialysis Devices And Equipment, Urinary Stone Treatment Devices And Equipment, Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment, Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment, Endoscopy Devices And Equipment, Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints, Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables, Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices, Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices The global medical equipment market grew from $639.75 billion in 2022 to $695.05 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global medical equipment is expected to grow to $922.39 billion in 2027 at a CAGR of 7.3%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020. This is increasing the demand for medical devices used in the diagnosis, prognosis, and treatment of several diseases, thereby driving the demand for medical equipment. These factors are expected to increase the patient pool globally, thereby driving the growth of the medical equipment market during the forecast period. Major companies in the medical equipment market include Medtronic Inc., Abbott Laboratories, Johnson & Johnson, Cardinal Health, Inc., Becton Dickinson, Siemens AG, STRYKER CORPORATION, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., and Boston Scientific Corporation. Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. For instance, according to cookieyed data 2021, in the US, PwC reported that 68% of 200 businesses surveyed intended to spend between $1 million and $10 million to comply with GDPR regulations. The GDPR regulation is an EU law on data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the medical equipment market. Device performance and patient data are available to healthcare service providers and are helping them to improve patient monitoring and overall care quality. Some companies are integrating medical equipment market data with EMR (Electronic Medical Records) to improve transparency and collaboration. As consumer wearables are becoming more common, patient data volumes are increasing and companies are investing in deploying data management, warehousing, and security technologies. For example, Medtronic launched a tool to augment their cardiac devices to securely transfer device data to doctors and allow them to monitor the critical health indicators of their patients. North America was the largest region in the global medical equipment market in 2022. Asia-Pacific was the second largest region in the global medical equipment market share. The regions covered in the medical equipment market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the medical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical equipment market consists of sales of devices used in the diagnosis, treatment and monitoring of medical conditions. The market includes diagnostic devices, imaging devices, surgical devices and patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in the medical equipment market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified medical equipment market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the medical equipment market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The medical equipment market research report is one of a series of new reports from The Business Research Company that provides medical equipment market statistics, including medical equipment industry global medical equipment market size, regional shares, competitors with a medical equipment market share, detailed medical equipment market segments, medical equipment market trends and opportunities, and any further data you may need to thrive in the medical equipment industry. This medical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Robotic surgery devices help doctors perform complex minimally invasive operations with precision and flexibility. The main product and services in the robotic surgery devices market are robotic systems, instruments and accessories, and services. The services are provided by the robots and are also called robot-assisted surgery services. The various surgery types are urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and others. These are used in hospitals and ambulatory surgery centres. The global robotic surgery devices market is segmented - 1) By Product and Service: Robotic systems, Instruments & Accessories, Services 2) By Surgery Type: Urological surgery, Gynecological surgery, Orthopedic surgery, Neurosurgery, Other Surgery Types 3) By End User: Hospitals, Ambulatory Surgery Centers The global robotic surgery devices market size will grow from $6 billion in 2022 to $6.84 billion in 2023 at a compound annual growth rate (CAGR) of 14.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global robotic surgery devices is expected to grow from $11.65 billion in 2027 at a CAGR of 14.2%. The rise in demand for minimally invasive technology is driving the robotic surgery devices market. Minimally Invasive (MI) surgery devices are equipped with imaging and catheter technologies that can be easily inserted into any part of the body. Robotic surgery procedures are usually associated with minimally invasive surgeries. These technologies are mainly used for heart, laparoscopy, orthopedic, gynecological, and urological surgeries. Robotic surgeries were introduced to reduce patient hospital length of stay (LOS), pain, complications, return to work time, and reoperations. According to the Intuitive Surgical company report, there is a 24% growth year on year for instruments and accessories. For robotic systems, the company has gained 16% growth and the overall robotic surgery devices market is growing at a rate of 13% -16%. The Intuitive Surgical company estimates that more than 1.2 million surgical procedures were done by using their robotic systems. Consumer preferences are changing, and hospitals are adopting robotic surgery devices to create more value and cost-effective surgical procedures. Major players in the robotic surgery devices market are Intuitive Surgical, Stryker, Medtronic, Smith & Nephew, TransEnterix, Mazor Robotics, Medrobotics, Accuray, THINK Surgical, and TINAVI Medical Technology Co. Ltd. Expensive robotic surgery is hampering the robotic surgery devices market. Robotic surgery is comparatively more expensive than other traditional ways of surgeries as it is associated with a lot of complications, requires highly trained senior doctors to operate robotic systems/instruments, complex technical operations, and maintenance. A single robotic system costs around $2 million and the surgery costs about a range of $3000 - $6000. The annual maintenance cost of robotic surgery devices usually costs between $100,000 - $170,000. The largest robotic surgery device manufacturer Intuitive Surgical supplies the single-use or disposable surgical tools used for robotic arms for surgeries. This is one of the reasons that robotic surgeries are more costly. The huge cost associated with robotic surgeries is therefore hindering the market growth. The advances in surgical products and technologies in the health care industry are creating more opportunities in the robotic surgery devices market. Increasing investments in R&D is helping investors to create value for the customers by producing medical-surgical products like robotic surgery devices by using the latest technologies. With the use of robotic systems that are equipped with optical imaging, surgical tools, instruments, and accessories, the surgeries are made easier. Some of the surgical advances that are creating more value and opportunity in the healthcare industry include 3-D high definition endoscope (Multi-Angle Rear-Viewing Endoscopic tool) devices for Brain surgery, Smart surgical glasses (equipped with a video camera and Head-mounted monitor) that act like computers, and can use for live observation of surgeries, surgical robots with artificial intelligence that acts as doctors, and humanoid robots which are used for highly critical surgeries in eye and brain. The other advanced surgical tool is remote robotics, which is used to assist with surgery from any remote location. Therefore, robotic surgery devices are playing an important role in the healthcare industry with their technological advancements and innovations. In February 2020, Medtronic PLC., a US-based medical device manufacturer, acquired Digital Surgery for an undisclosed amount. The acquisition would help Medtronic in clinical decision support and reduce its cost. It will also help them to grow in the robotic surgery vertical. Digital Surgery is a UK-based manufacturer of digital surgical tools. North America was the largest region in the robotic surgery devices market in 2022. Western Europe was the second largest market in robotic surgery devices market report. The regions covered in the robotic surgery devices analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the robotic surgery devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and USA. Robotic surgery equipment market consist of sales of robotic systems, instruments and accessories that are used for robotic surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The robotic surgery devices market research report is one of a series of new reports from The Business Research Company that provides robotic surgery devices market statistics, including robotic surgery devices industry global market size, regional shares, competitors with a robotic surgery devices market share, detailed robotic surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the robotic surgery devices industry. This robotic surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Refractive surgery devices and equipment are used in refractive error surgeries, a procedure for correcting or improving vision affected by a refractive error such as nearsightedness (myopia), farsightedness (hyperopia), presbyopia, or astigmatism. The main product types of refractive surgery devices (or) equipment are microkeratome, excimer lasers, femtosecond lasers, and YAG lasers. The excimer laser is a laser that emits concentrated light in the ultraviolet (UV) region of the spectrum. The various applications involved are astigmatism, near-sightedness, and farsightedness that are used by end-users such as hospitals, ambulatory surgical centres, and ophthalmology clinics. The global refractive surgery devices and equipment market is segmented - 1) By Product Type: Microkeratome, Excimer Lasers, Femtosecond Lasers, YAG Lasers 2) By End User: Hospitals, Ambulatory Surgical Centres, Opthalmology Clinics 3) By Application: Astigmatism, Near-sightedness, Farsightedness The global refractive surgery devices and equipment market size will grow from $0.15 billion in 2022 to $0.17 billion in 2023 at a compound annual growth rate (CAGR) of 10.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global refractive surgery devices and equipment is expected to grow to $0.24 billion in 2027 at a CAGR of 9.5%. A significant driving factor for the growth of the Refractive surgery devices and equipment market is an increase in the geriatric population worldwide with eye disorders. Age-related macular degeneration is the major cause of loss of vision over the age of 65 years. There are many elderly people with refractive errors who require immediate surgical care to cure visual impairment. The rising elderly population throughout the year increases the demand for refractive surgeries. For example, the elderly population in USA is steadily growing and by 2030, 70 million Americans will be over 65 years of age. Approximately one in three older people have optic disorders which are boosting the refractive surgery devices and equipment market. Major players in the refractive surgery devices (or) equipment market are Alcon, J & J, Zeiss, Bausch, and Lomb (Valeant), Ziemer Ophthalmic, Nidek, STAAR, Avedro, Lensar, and iVIS Technologies. The Refractive surgery devices and equipment market is being restrained due to the lack of use of surgical equipment to treat refractive errors, in developing nations. Also, backwardness, poverty, and lack of knowledge make the patients unaware of the procedures of the surgery. For example, according to WHO the visual impairment in Rwanda, an African country is 5.3% and more than 80% of the eye cases were refractive errors which were considered treatable but due to lack of ophthalmic surgical devices there is no cure. People in developing countries witness more cases related to blindness than in developed countries. The focus areas for many companies in the refractive surgery devices and equipment market has shifted towards increasing technological advancements in the field of refractive surgery. Advanced technologies used for correcting refractive errors expand the scale of the treatment, reduce the time and labor costs. The new corneal refractive surgical techniques such as femtosecond corneal surgery technique, pseudophakic intraocular lenses, intraocular rings and segments, and corneal stiffening techniques such as collagen crosslinking may impact the market significantly. For instance, the intrastromal femtosecond laser-assisted lenticular corneal excision (Flex-Smile) technique is very effective for myopic cases of up to 10 diopters with astigmatism up to 3. Also, the advanced femtosecond laser surgical instruments have many unique features such as complete surgical control down to the micron in terms of diameter, depth and edge angle, fast flap creation. In the USA, FDA (Foods and Drugs Administration) regulates the sale of medical devices and monitors the safety of all regulated medical devices. FDA regulates the sales of medical devices for refractive surgery. North America was the largest region in the global refractive surgery devices (or) equipment market in 2022. Asia-Pacific was the second-largest region in the refractive surgery devices (or) equipment market. The regions covered in the global refractive surgery devices (or) equipment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the refractive surgery devices (or) equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia. The Refractive surgery devices and equipment market consist of sales of microkeratome, excimer lasers, femtosecond lasers, YAG lasers, and aberrometers that are used for refractive surgeries. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The refractive surgery devices (or) equipment market research report is one of a series of new reports from The Business Research Company that provides refractive surgery devices (or) equipment market statistics, including refractive surgery devices (or) equipment industry global market size, regional shares, competitors with a refractive surgery devices (or) equipment market share, detailed refractive surgery devices (or) equipment market segments, market trends and opportunities, and any further data you may need to thrive in the refractive surgery devices (or) equipment industry. This refractive surgery devices (or) equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Robotic surgery is a form of minimally invasive surgery in which doctors insert a succession of extremely small incisions and tiny surgical equipment into a patient's body. Robotic surgery is the process of performing a surgery using tools that are attached to a robotic arm. It is used to perform surgery with high precision. The robotic surgery services are used in various applications such as general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and others. General surgery is the branch of surgery that deals with the most common surgical procedures. The abdomen, breasts, head and neck, blood arteries, and digestive tract are all treated by general surgeons. They also oversee the treatment of patients who have been wounded, or who have abnormalities or other medical issues that necessitate surgery. The different sectors include hospitals, ambulatory surgery centres (ASCs) and involves various components such as systems, accessories, services. The global robotic surgery services market is segmented - 1) By Component: Systems, Accessories, Services 2) By Application: General Surgery, Urological Surgery, Gynecological Surgery, Orthopedic Surgery, Neurosurgery, Other Applications 3) By End-User: Hospitals, Ambulatory Surgery Centers (ASCs) The global robotic surgery services market size will grow from $0.86 billion in 2022 to $1.01 billion in 2023 at a compound annual growth rate (CAGR) of 17.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global robotic surgery services is expected to grow to $1.8 billion in 2027 at a CAGR of 15.4%. Increase in purchasing power of hospitals and ambulatory care services has helped in the growth of the robotic surgery service market. Hospitals and ambulatory care services are interested in buying latest technologies to provide advanced care to the patients as well as to achieve an edge over their competitors. According to the fourth quarter and full year financial results 2021 of Intuitive Surgical, the robotic surgical giant, the company shipped 385 da Vinci Surgical Systems in fourth quarter, up 18% from the third quarter's 326 units shipped. In 2021, the company shipped 1,347 da Vinci Surgical Systems, a 44% increase from the 936 systems shipped in 2020.Therefore, the purchasing power of hospital and ambulatory care services coupled with the increase in the geriatric population and prevalence of chronic illness have contributed to the growth of the robotic surgery services market. Major players in the robotic surgery services market are Intuitive Surgical Inc., Stryker Corporation, Medrobotics Corporation, Johnson & Johnson, Globus medicals, NuVasive, Smith & Nephew PLC., Titan Medical Inc., TransEnterix Inc. and University of Pittsburgh Medical Centre. Safety concerns regarding the use of robotic surgery services are likely to cause a hindrance to the robotic surgery services market. According to a study on adverse events with robotic-assisted arthroplasty by American Academy of Orthopedic Surgeons, the unexpected robotic arm movement during bone cuts during TKA was the most common adverse event (AE), accounting for 28.9% of all reported AEs, followed by erroneous bone cuts (12.7%) and the robotic component leaking fluid or having residual contaminants (12.3 percent). Accurate bone resections accounted for more than a quarter of all adverse events associated with robotic-assisted PKA. A registration checkpoint being left in the patient accounted for 43.2 percent of all reported adverse events (AEs) in THA patients. Therefore, the safety issues pertaining to robotic surgeries leading to product recalls is expected to hinder the growth of the robotic surgery services market. The image guide navigation system combined with the robotic surgery system offers more possibility to visualize and perform minimally invasive surgery in areas that were earlier difficult, especially the orthopedic surgeries and neurosurgeries. The Mazor X Stealth system by Medtronic, and the NuVasive's Pulse and Excelsius GPS by Globus Medical, among others use image-guided navigation systems to perform spine surgeries, and orthopaedic implant surgeries such as total, partial knee, and hip replacements as they provide the surgeon with 3D experience. The image-guided navigation reduces the radiation effects and patients do not require to take an X-ray after the procedure. These factors state that the image-guided navigation system is expected to be a trend in robotic surgery services. In February 2022, Medtronic PLC., a US-based medical device company, acquired Digital Surgery for an undisclosed amount. Through this acquisition, Digital Surgery will enhance Medtronic's robotic-assisted surgery platform and expand Medtronic's wider range of products. Digital Surgery is a UK-based is a privately held pioneer in digital education and training, data and analytics, and surgical artificial intelligence (AI). North America was the largest region in the robotic surgery services market in 2022. Western Europe was the second largest region in the global robotic surgery services market share.The regions covered in the global robotic surgery services market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the robotic surgery services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The robotic surgery services market includes revenues earned by entities by providing robotic gynaecological services, robotic prostate surgery services, robotic kidney surgery services, and robotic colorectal surgery services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced.It does not include revenues from resales either further along the supply chain or as part of other products. The robotic surgery services market research report is one of a series of new reports from The Business Research Company that provides robotic surgery services market statistics, including robotic surgery services industry global market size, regional shares, competitors with a robotic surgery services market share, detailed robotic surgery services market segments, market trends and opportunities, and any further data you may need to thrive in the robotic surgery services industry. This robotic surgery services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.